Preleukemia: Clinical Trials

2 trials for Preleukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow Preleukemia: new trials by email Literature Review of Preleukemia trials Research Report on Preleukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
Busulfan, Fludarabine, PBSC Hematopoietic Stem Cell Transplantation (HSCT) - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2Active not recruitingCenter for International Blood and Marrow Transplant Research3132023-12-082026-08-17
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Busulfan, Fludarabine, Total-body irradiation - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
Phase 2Active not recruitingCenter for International Blood and Marrow Transplant Research3002021-09-302026-03-18

Narrower conditions

Bone Marrow Diseases (2)  ·  Hematologic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, B-Cell (2)  ·  Leukemia, Biphenotypic, Acute (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Lymphoid (2)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2)  ·  Leukemia, Myeloid (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoproliferative Disorders (2)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Myelodysplastic-Myeloproliferative Diseases (1)  ·  Myeloproliferative Disorders (1)

Interventions

Busulfan (2)  ·  Cyclophosphamide (2)  ·  Melphalan (2)  ·  Mesna (2)  ·  Mycophenolic Acid (2)  ·  Patient Reported Outcome Measures (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  Tacrolimus (2)  ·  Whole-Body Irradiation (2)  ·  fludarabine (2)  ·  fludarabine phosphate (2)  ·  Bone Marrow Transplantation (1)

Sponsors

Center for International Blood and Marrow Transplant Research (2)

Countries

United States (2)

Top investigators

Steven Devine, MD (2)  ·  Ginna Laport, MD (1)

Results publications

PMID 40523209, PMID 42448319, PMID 42616616